• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶-3在多巴胺能细胞凋亡过程中的一种新的细胞内作用。

A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells.

作者信息

Choi Dong Hee, Kim Eun-Mee, Son Hyo Jin, Joh Tong H, Kim Yoon Seong, Kim Donghou, Flint Beal M, Hwang Onyou

机构信息

Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

J Neurochem. 2008 Jul;106(1):405-15. doi: 10.1111/j.1471-4159.2008.05399.x. Epub 2008 Jul 1.

DOI:10.1111/j.1471-4159.2008.05399.x
PMID:18397366
Abstract

We have previously demonstrated that the active form of matrix metalloproteinase-3 (actMMP-3) is released from dopamine(DA)rgic neurons undergoing apoptosis. Herein, whether actMMP-3 might be generated intracellularly, and if so, whether it is involved in apoptosis of DArgic neurons itself was investigated in primary cultured DArgic neurons of wild-type, MMP-3 knockout animals, and CATH.a cells. During apoptosis, gene expression of MMP-3 is induced, specifically among the various classes of MMPs, generating the proform (55 kDa) which is subsequently cleaved to the catalytically active actMMP-3 (48 kDa) involving a serine protease. Intracellular actMMP-3 activity is directly linked to apoptotic signaling in DArgic cells: (i) Pharmacologic inhibition of enzymatic activity, repression of gene expression by siRNA, and gene deficiency all lead to protection; (ii) pharmacologic inhibition causes attenuation of DNA fragmentation and caspase 3 activation, the indices of apoptosis; and (iii) inhibition of the pro-apoptotic enzyme c-Jun N-terminal protein kinase leads to repression of MMP-3 induction. Under the cell stress condition, MMP-3 is released as actMMP-3 rather than the proform (proMMP-3), and catalytically active MMP-3 added to the medium does not cause cell death. Thus, actMMP-3 seems to have a novel intracellular role in apoptotic DArgic cells and this finding provides an insight into the pathogenesis of Parkinson's disease.

摘要

我们之前已经证明,基质金属蛋白酶-3(actMMP-3)的活性形式是从正在经历凋亡的多巴胺能(DA)神经元中释放出来的。在此,我们在野生型、MMP-3基因敲除动物的原代培养多巴胺能神经元以及CATH.a细胞中研究了actMMP-3是否可能在细胞内产生,如果是,它是否参与多巴胺能神经元自身的凋亡。在凋亡过程中,MMP-3的基因表达被诱导,特别是在各类基质金属蛋白酶中,产生前体形式(55 kDa),随后该前体被切割成具有催化活性的actMMP-3(48 kDa),这一过程涉及一种丝氨酸蛋白酶。细胞内的actMMP-3活性与多巴胺能细胞中的凋亡信号直接相关:(i)酶活性的药理抑制、siRNA对基因表达的抑制以及基因缺陷都能导致细胞得到保护;(ii)药理抑制会导致DNA片段化和半胱天冬酶3激活减弱,而这两者是凋亡的指标;(iii)对促凋亡酶c-Jun N末端蛋白激酶的抑制会导致MMP-3诱导的抑制。在细胞应激条件下,MMP-3以actMMP-3而非前体形式(proMMP-3)释放,并且添加到培养基中的具有催化活性的MMP-3不会导致细胞死亡。因此,actMMP-3似乎在凋亡的多巴胺能细胞中具有一种新的细胞内作用,这一发现为帕金森病的发病机制提供了深入了解。

相似文献

1
A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells.基质金属蛋白酶-3在多巴胺能细胞凋亡过程中的一种新的细胞内作用。
J Neurochem. 2008 Jul;106(1):405-15. doi: 10.1111/j.1471-4159.2008.05399.x. Epub 2008 Jul 1.
2
Matrix metalloproteinase-3 contributes to vulnerability of the nigral dopaminergic neurons.基质金属蛋白酶-3 导致黑质多巴胺能神经元易损性。
Neurochem Int. 2010 Jan;56(1):161-7. doi: 10.1016/j.neuint.2009.09.014. Epub 2009 Oct 6.
3
Regulation of matrix metalloproteinase-9 gene expression in MPP+- or 6-OHDA-treated human neuroblastoma SK-N-BE(2)C cells.MPP+ 或 6-OHDA 处理的人神经母细胞瘤 SK-N-BE(2)C 细胞中基质金属蛋白酶-9 基因表达的调控。
Neurochem Int. 2010 Feb;56(3):437-42. doi: 10.1016/j.neuint.2009.11.019. Epub 2009 Dec 3.
4
Critical role of ASK1 in the 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells.凋亡信号调节激酶1(ASK1)在6-羟基多巴胺诱导的人神经母细胞瘤SH-SY5Y细胞凋亡中的关键作用
J Neurochem. 2006 Apr;97(1):234-44. doi: 10.1111/j.1471-4159.2006.03730.x. Epub 2006 Mar 3.
5
A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation.基质金属蛋白酶-3活性通过小胶质细胞激活在多巴胺能神经元变性中起关键作用。
FASEB J. 2007 Jan;21(1):179-87. doi: 10.1096/fj.06-5865com. Epub 2006 Nov 20.
6
Differential effect of nerve growth factor on dopaminergic neurotoxin-induced apoptosis.神经生长因子对多巴胺能神经毒素诱导的细胞凋亡的差异作用。
J Neurochem. 2006 Oct;99(2):416-25. doi: 10.1111/j.1471-4159.2006.04006.x.
7
JNK activation by tetrahydrobiopterin: implication for Parkinson's disease.四氢生物蝶呤激活JNK:对帕金森病的影响。
J Neurosci Res. 2004 Mar 1;75(5):715-21. doi: 10.1002/jnr.20012.
8
A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats.一种细胞穿透肽抑制剂TAT-JBD可降低MPP⁺诱导的半胱天冬酶-9激活,但不能预防大鼠黑质中的多巴胺能神经元变性。
Toxicology. 2008 Jan 14;243(1-2):124-37. doi: 10.1016/j.tox.2007.09.033. Epub 2007 Oct 18.
9
K252a prevents nigral dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1/JNK3 signaling pathways.K252a通过抑制混合谱系激酶3/ c-Jun氨基末端激酶3(JNK3)和凋亡诱导激酶1/ JNK3信号通路,预防6-羟基多巴胺诱导的黑质多巴胺能细胞死亡。
Mol Pharmacol. 2007 Dec;72(6):1607-18. doi: 10.1124/mol.107.038463. Epub 2007 Sep 13.
10
HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells.组蛋白去乙酰化酶抑制剂曲古抑菌素 A 抑制多巴胺能神经元细胞的存活。
Neurosci Lett. 2009 Dec 31;467(3):212-6. doi: 10.1016/j.neulet.2009.10.037. Epub 2009 Oct 14.

引用本文的文献

1
The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.胰高血糖素样肽1在阿尔茨海默病和帕金森病中的神经保护作用:深入综述
Front Neurosci. 2022 Sep 1;16:970925. doi: 10.3389/fnins.2022.970925. eCollection 2022.
2
Novel Roles of MT1-MMP and MMP-2: Beyond the Extracellular Milieu.MT1-MMP 和 MMP-2 的新角色:超越细胞外环境。
Int J Mol Sci. 2022 Aug 23;23(17):9513. doi: 10.3390/ijms23179513.
3
Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson's disease.
帕金森病患者基质金属蛋白酶3和基质金属蛋白酶9水平与非运动症状的相关性
Front Aging Neurosci. 2022 Aug 22;14:889257. doi: 10.3389/fnagi.2022.889257. eCollection 2022.
4
Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases.基质金属蛋白酶(MMPs)的性别差异:这些生物标志物在心血管疾病和神经疾病中的新视角
J Pers Med. 2022 Jul 22;12(8):1196. doi: 10.3390/jpm12081196.
5
Metalloproteinases and their inhibitors in neurological disease.神经疾病中的金属蛋白酶及其抑制剂。
Naunyn Schmiedebergs Arch Pharmacol. 2022 Jan;395(1):27-38. doi: 10.1007/s00210-021-02188-x. Epub 2021 Dec 1.
6
Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders.血脑屏障功能障碍作为神经退行性疾病的潜在治疗靶点。
Arch Pharm Res. 2021 May;44(5):487-498. doi: 10.1007/s12272-021-01332-8. Epub 2021 May 24.
7
Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.基质金属蛋白酶在神经退行性疾病中的多效性作用:病理生理和治疗观点。
Int J Mol Sci. 2021 Jan 30;22(3):1413. doi: 10.3390/ijms22031413.
8
MMP13 Expression Is Increased Following Mutant α-Synuclein Exposure and Promotes Inflammatory Responses in Microglia.突变型α-突触核蛋白暴露后MMP13表达增加并促进小胶质细胞的炎症反应。
Front Neurosci. 2020 Dec 2;14:585544. doi: 10.3389/fnins.2020.585544. eCollection 2020.
9
Cypermethrin Induces the Activation of Rat Primary Microglia and Expression of Inflammatory Proteins.氯菊酯诱导大鼠原代小胶质细胞的激活和炎症蛋白的表达。
J Mol Neurosci. 2021 Jun;71(6):1275-1283. doi: 10.1007/s12031-020-01753-y. Epub 2020 Nov 23.
10
Promising Molecular Targets for Pharmacological Therapy of Neurodegenerative Pathologies.神经退行性疾病药物治疗的潜在分子靶点
Acta Naturae. 2020 Jul-Sep;12(3):60-80. doi: 10.32607/actanaturae.10925.